Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7316 p337
11 September 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Patients with COPD are missing out on treatment

Patients with chronic obstructive pulmonary disease (COPD) may be missing out on appropriate treatment, according to a primary care study presented at the European Respiratory Society meeting in Glasgow this week.

The study recruited 597 patients aged 40 or older with prior diagnoses or taking medicines consistent with COPD though not previously diagnosed with this condition.

David Price from Aberdeen University said that 40 per cent of these patients were found to have COPD. Half had been diagnosed with asthma only and 10 per cent had no prior diagnosis of obstructive lung disease. “The level of misdiagnosis and underdiagnosis seen in this study is concerning,” he remarked.“It is time for primary care professionals to rethink their approach to COPD to ensure patients receive an early, correct diagnosis and appropriate effective treatment,” he stated. The study was supported by Boehringer Ingelheim and Pfizer.

The ERS conference also heard that more than half of COPD patients were failing to notify their GPs of an exacerbation. Investigator John O’Reilly, University Hospital, Aintree, said: “By not reporting their exacerbations, COPD patients are not receiving treatment needed to manage their condition and help prevent further episodes.”

Back to Top


©The Pharmaceutical Journal